A federal judge tripled damages against the pharmacy benefits manager after finding it encouraged inflated Medicare drug ...

Wes Streeting has walked away from talks with pharmaceutical giants on NHS drug costs amid a stand-off over rebates. The ...

The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...

The thyroid gland disorder treatments market is witnessing substantial growth, fueled by the increasing incidence of conditions like hypothyroidism and hyperthyroidism. Greater awareness about the ...

The pharmaceutical drug delivery market is entering a transformative phase, projected to grow from USD 1,949.4 billion in ...

Influenza Pipeline Summary. DelveInsight’s Influenza Emerging Drugs report highlights innovative therapies advancing the ...

Dynavax (DVAX) stock gains as the company's Z-1018 shingles shot shows immune response comparable to GSK's (GSK) Shingrix vaccine in a Phase 1/2 trial. Read more here.

It's a household name targeting a dental condition that affects a reported 40 million Americans. Here's what to know if ...

With three new antibiotics set to shake up the stagnant treatment landscape for uncomplicated urinary tract infections (uUTIs ...

The global Zoonotic Disease Treatment Market, valued at USD 46.4 billion in 2025, is projected to grow to USD 82.3 billion by ...

Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration ...

Saez-Rodriguez reports funding from GSK, Pfizer and Sanofi and fees/honoraria from Travere Therapeutics, Stadapharm, Astex, Pfizer, Grunenthal, Moderna and Tempus Labs. Kuehl is an employee of and ...